Bagsværd, Denmark, 10 July 2024 – Novo Nordisk today announced that the US Food and Drug Administration (FDA) has issued a Complete Response Letter (CRL) covering the Biologics License Application for once-weekly basal insulin icodec for the treatment of diabetes mellitus. In the letter, the FDA has requests related to the manufacturing process and the […]
Category Archives: Pr Newswire
11
Jul
Jul
TORONTO, July 10, 2024 (GLOBE NEWSWIRE) — Avicanna Inc. (“Avicanna” or the “Company”) (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN) a biopharmaceutical company focused on the development, manufacturing, and commercialization of plant-derived cannabinoid-based products is pleased to announce that all of management’s nominees listed in the Company’s Management Information Circular dated May 31, 2024 (“Circular”) were […]
WILMSTEAD, Curacao, July 11, 2024 /PRNewswire/ — N1 Bet, a leading casino and betting brand, has unveiled one of the biggest and unique promotional campaigns in the brand’s history – the Mega Casino Race. Players have the chance to win awesome prizes, including a Ford Ranger Raptor, a Tesla Model Y, and more, with a […]
HONG KONG, July 11, 2024 /PRNewswire/ — MMTEC, Inc. (NASDAQ: MTC) (“MMTEC”, “we”, “our” or the “Company”), a China-based technology company that provides access to the U.S. financial markets, today announced that on July 8, 2024, the Company received a notification letter (the “Notification Letter”) from the Listings Qualifications Department of The Nasdaq Stock Market LLC […]
Beginning July 9, 2024, Consumers Will Find Imbox Protection in Stores Providing a PFAs-Free Treatment in 60 seconds at Check Out DENMARK and HONG KONG, July 11, 2024 /PRNewswire/ — IMBOX Protection, the world’s only in-store footwear protection technology, is expanding its presence in Asia beginning July 9, 2024, partnering with Hong-Kong-based Sportshouse, a leading sports […]
EmpowerMX’s powerful MRO technology adds further differentiation and depth to IFS’s Industrial AI proposition for Aerospace & Defense FRISCO, Texas, July 11, 2024 /PRNewswire/ — IFS, the leading technology innovator in cloud and Industrial AI software, today announces the acquisition of EmpowerMX. EmpowerMX is an AI-powered aviation maintenance software provider specializing in Airframe Maintenance Repair and […]
Wireless Planar Magnetic Headphones to accurately represent a superior audio experience. The 2nd gen EqualMass™ wiring technology and 2μm thin film lend the STAX SPIRIT S5 a performance comparable to legendary electrostatic headphones. Production Phase Auto Calibrate guarantees that every set of S5 headphones delivers a sound fidelity identical to the original model crafted by […]
Pr Newswire
Recce Pharmaceuticals Announces Positive Preclinical Efficacy Data Against WHO Priority Pathogen Acinetobacter baumannii
10
Jul
Jul
RECCE® 327 (R327) demonstrated significant bactericidal activity against ‘superbug’ Acinetobacter baumannii (A. baumannii) demonstrating 99.99999% log reduction (>7.5 log reduction) in adult human epidermal ‘skin’ cells A. baumannii is most commonly responsible for urinary tract infections, ventilator-associated pneumonia, central line-associated bloodstream infections, persistent wound infections and meningitis The data supports upcoming Phase II Acute Bacterial […]
10
Jul
Jul
SOMERSET, N.J., July 10, 2024 (GLOBE NEWSWIRE) — Legend Biotech Corporation (NASDAQ: LEGN) (Legend Biotech), a global leader in cell therapy, will host a conference call for investors at 8:00 am ET on Friday, August 9, 2024, to review second-quarter 2024 results. During the webcast and conference call, senior leaders will provide an overview of […]
Pr Newswire
Tr1X Announces First Patient Dosed in Proof of Concept GvHD Trial Evaluating TRX103, a First-in-Class Type 1 Treg (Tr1) Cell Therapy
10
Jul
Jul
TRX103 is designed to reset the immune system, improve clinical outcomes, and potentially cure patients suffering from autoimmune and inflammatory disorders This marks the first use of an allogeneic engineered Type 1 Treg (Tr1) cell therapy in clinical trials. The first patient has successfully cleared the safety period with no serious adverse events. Additional preliminary […]